-+ 0.00%
-+ 0.00%
-+ 0.00%

ARTIVA BIOTHERAPEUTICS - EXPECTS PHASE 3 RA TRIAL TOPLINE RESULTS BY END OF 2028

Reuters·09/08/2026 11:30:01

Please log in to view news